First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

BACKGROUND: The nadir value of the absolute neutrophil count (ANC) in the first cycle of chemotherapy is an effective predictor of subsequent neutropenic events. This study was designed to validate an earlier published study based on a retrospective data analysis from a prospective randomized clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314422/
https://www.ncbi.nlm.nih.gov/pubmed/12927041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314422/
https://www.ncbi.nlm.nih.gov/pubmed/12927041

Ejemplares similares